Depressive sygdomme blev rapporteret hos 3, 2% af obese patienter, eller overvægtige patienter med associerede risikofaktor( er) i behandling med rimonabant 20 mg.
Depressive disorders were reported in 3.2% of obese patients, or overweight patients with associated risk factor(s) treated with rimonabant 20 mg.